COSMOS HEALTH INC(COSM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

COSM COSMOS HEALTH INC

Pre-Mkt 01-12 07:46:36 EST

0.5499

+0.0313

+6.04%

High0.5700	Low0.5111	Vol1.07M
Open0.5200	D1 Closing0.5186	Amplitude11.36%
Mkt Cap20.50M	Tradable Cap15.56M	Total Shares37.28M
T/O582.35K	T/O Rate3.79%	Tradable Shares28.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"COSM","market":"US","secType":"STK","nameCN":"COSMOS HEALTH INC","latestPrice":0.5499,"timestamp":1767992400000,"preClose":0.5186,"halted":0,"volume":1072300,"delay":0,"floatShares":28303000,"shares":37281700,"eps":-0.689062,"marketStatus":"Pre-Mkt","change":0.0313,"latestTime":"01-12 07:46:36 EST","open":0.52,"high":0.57,"low":0.5111,"amount":582346.61414,"amplitude":0.113575,"askPrice":0.58,"askSize":244,"bidPrice":0.5499,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.689062,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768228200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5499,"postHourTrading":{"tag":"盘后","latestPrice":0.5533,"preClose":0.5499,"latestTime":"19:22 EST","volume":6163,"amount":3369.7807,"timestamp":1768004573128},"volumeRatio":2.1430121398602173,"impliedVol":0.734,"impliedVolPercentile":0.324},"requestUrl":"/m/hq/s/COSM/wiki","defaultTab":"wiki","newsList":[{"id":"2602308801","title":"Cosmos Health CEO Grigorios Siokas Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602308801","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602308801?lang=en_us&edition=fundamental","pubTime":"2026-01-10 00:44","pubTimestamp":1767977068,"startTime":"0","endTime":"0","summary":"Grigorios Siokas, Chief Executive Officer and beneficial owner of Cosmos Health Inc., has reported the acquisition of common shares of Cosmos Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL6rqkt9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cosmos Health CEO Grigorios Siokas Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2601938819","title":"Cosmos Health Inc. CEO Grigorios Siokas Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601938819","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601938819?lang=en_us&edition=fundamental","pubTime":"2026-01-08 02:01","pubTimestamp":1767808886,"startTime":"0","endTime":"0","summary":"Grigorios Siokas, Chief Executive Officer and Director of Cosmos Health Inc., has reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL83p1h6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cosmos Health Inc. CEO Grigorios Siokas Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2601623887","title":"Cosmos Health Inc - to Manufacture Pharmaceutical Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2601623887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601623887?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:30","pubTimestamp":1767623430,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60V3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2601887602","title":"Cosmos Health Secures Five-Year PathMuscle Manufacturing Agreement with Libytec","url":"https://stock-news.laohu8.com/highlight/detail?id=2601887602","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601887602?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:30","pubTimestamp":1767623412,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. announced that its wholly owned subsidiary, Cana Laboratories, has entered into a manufacturing and supply agreement with Libytec Pharmaceutical S.A. for the production of the pharmaceutical product PathMuscle. Under the terms of the agreement, Cosmos Health will be responsible for the end-to-end manufacturing of PathMuscle, including formulation, production, quality control, and product release, in compliance with regulatory requirements. The contract includes firm minimum committed production volumes of 591,500 units and anticipates cumulative production volumes over a five-year period to exceed 1.2 million units, subject to market demand and commercial performance. PathMuscle will be distributed and commercially promoted in Greece by Libytec Pharmaceutical S.A.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for infor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL9cM3js:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014039.USD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","LU2210149790.SGD","LU0314104364.USD","BK4585","IE00BGHQF748.EUR","COSM","BK4588","BK4112","IE00BKPKM429.USD","SG9999014021.USD","LU2095319765.USD","IE00B3QW5Z07.USD","BK4175","SG9999014013.SGD"],"gpt_icon":0},{"id":"2601688768","title":"Cosmos Health Enters Manufacturing Agreement With Libytec for Pathmuscle Medicine, With Five-Year Volumes Expected to Exceed 1.2 Million Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2601688768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601688768?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:30","pubTimestamp":1767623400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA7CXS4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2593777704","title":"Cosmos Health Inc. Announces Plans to Expand U.S. Market Presence Through Domestic Manufacturing and Vertically Integrated Healthcare Platform to Mitigate Tariff Risks and Strengthen Supply Chain Resilience","url":"https://stock-news.laohu8.com/highlight/detail?id=2593777704","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593777704?lang=en_us&edition=fundamental","pubTime":"2025-12-24 22:00","pubTimestamp":1766584836,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. Announces Plans to Expand U.S. Market Presence Through Domestic Manufacturing and Vertically Integrated Healthcare Platform to Mitigate Tariff Risks and Strengthen Supply Chain Resilience. Cosmos Health Inc. has announced a strategy focused on expanding its vertically integrated platform across pharmaceuticals, nutraceuticals, and over-the-counter products. The company plans to scale its healthcare services component to support ongoing engagement and repeat interaction. As part of its U.S. market expansion, Cosmos Health is establishing domestic manufacturing capacity through an agreement with DolCas Biotech, aiming to produce products locally to mitigate tariff risks and strengthen supply chain resilience. The company’s approach emphasizes building long-term infrastructure and operational durability, with management increasing insider ownership as part of its overall planning.Disclaimer: This news brief was created by Public Technologies  using generative artificial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nNDL1cQDCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2593439838","title":"Cosmos Health Inc. CEO Grigorios Siokas Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593439838","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593439838?lang=en_us&edition=fundamental","pubTime":"2025-12-22 23:46","pubTimestamp":1766418363,"startTime":"0","endTime":"0","summary":"Grigorios Siokas, Chief Executive Officer of Cosmos Health Inc., has reported the acquisition of common shares of Cosmos Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL2tZ9K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cosmos Health Inc. CEO Grigorios Siokas Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2592342160","title":"Cosmos Health Reports Record Quarterly Revenue of Over $17 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2592342160","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592342160?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:01","pubTimestamp":1766152864,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. reported its highest quarterly revenue to date, exceeding $17 million. The company highlighted its recent capital actions, including CEO Greg Siokas's continued share purchases and a $500,000 investment in Ethereum, bringing total digital asset investments to over $2 million under a $300 million facility. Cosmos Health has expanded its operations with the acquisitions of ZipDoctor and Cloudscreen, broadening its services beyond products and increasing recurring engagement. The company maintains a diversified presence in pharmaceuticals, nutraceuticals, and healthcare services, and has emphasized operational discipline with manufacturing that meets European GMP standards and established distribution infrastructure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL5g94FN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2592008829","title":"Cosmos Health Faces Nasdaq Delisting Over Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2592008829","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592008829?lang=en_us&edition=fundamental","pubTime":"2025-12-18 23:24","pubTimestamp":1766071452,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. has received a non-compliance letter from Nasdaq after its stock price remained below the minimum bid requirement of $1.00 per share for thirty consecutive business days, as stipulated by Nasdaq Listing Rule 5550. The company has been given 180 calendar days from December 11, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days. If Cosmos Health is unable to meet this requirement, it plans to implement a reverse stock split to restore compliance and avoid potential delisting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL7yh8rs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2592939621","title":"Cosmos Health CEO Grigorios Siokas Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592939621","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592939621?lang=en_us&edition=fundamental","pubTime":"2025-12-17 01:18","pubTimestamp":1765905509,"startTime":"0","endTime":"0","summary":"Grigorios Siokas, Chief Executive Officer and Director of Cosmos Health Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL9mqMnp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cosmos Health CEO Grigorios Siokas Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2588025522","title":"Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2588025522","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588025522?lang=en_us&edition=fundamental","pubTime":"2025-12-04 01:20","pubTimestamp":1764782400,"startTime":"0","endTime":"0","summary":"CHICAGO, Dec.  03, 2025  (GLOBE NEWSWIRE) -- Cosmos Health Inc. (\"Cosmos Health\" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a long-t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/03/3199223/0/en/Cosmos-Health-Launches-Strategic-Partnership-With-Prime-Ledger-to-Transform-300M-Treasury-and-Tokenize-IP-Assets.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","BK4585","COSM","IE00B3T34201.USD","LU1481600234.SGD","LU1487256676.USD","LU2463526074.USD","DAT","BK4588","BK4081","LU1169590202.USD","BK4136","EMA","BK4175","LU1481599808.USD","IP"],"gpt_icon":0},{"id":"2588506660","title":"Cosmos Health CEO Greg Siokas Increases Shareholding by 3.4 Million Shares in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588506660","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588506660?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:15","pubTimestamp":1764695713,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. announced that CEO Greg Siokas has significantly increased his ownership in the company throughout 2025. Between November 19 and November 28, 2025, Mr. Siokas completed five transactions, acquiring a total of 301,101 shares. Year-to-date, he has added 3,398,055 shares to his holdings, bringing his total ownership to 6,459,985 shares of Cosmos Health.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire  on December 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL7RPCj2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","IE00B64PRP62.GBP","LU0314104364.USD","BK4588","LU2210150020.SGD","COSM","BK4175","IE00BGHQF748.EUR","BK4585","IE00BKPKM429.USD","NDAQ","BK4112","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2588774215","title":"Cosmos Health CEO Grigorios Siokas Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774215","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588774215?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:04","pubTimestamp":1764608655,"startTime":"0","endTime":"0","summary":"Grigorios Siokas, Chief Executive Officer of Cosmos Health Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL2dNR0X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cosmos Health CEO Grigorios Siokas Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2586492118","title":"Cosmos Health CEO Grigorios Siokas Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586492118","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586492118?lang=en_us&edition=fundamental","pubTime":"2025-11-25 03:48","pubTimestamp":1764013690,"startTime":"0","endTime":"0","summary":"Grigorios Siokas, Chief Executive Officer of Cosmos Health Inc., reported the acquisition of common shares of Cosmos Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL90Yh25:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cosmos Health CEO Grigorios Siokas Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2585715540","title":"Cosmos Health CEO Grigorios Siokas Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585715540","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585715540?lang=en_us&edition=fundamental","pubTime":"2025-11-21 00:06","pubTimestamp":1763654794,"startTime":"0","endTime":"0","summary":"Grigorios Siokas, Chief Executive Officer and Director of Cosmos Health Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL1wTYwz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cosmos Health CEO Grigorios Siokas Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"gpt_icon":0},{"id":"2584276969","title":"Cosmos Health Q3 Adjusted EBITDA USD 4.63 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584276969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584276969?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:53","pubTimestamp":1763574817,"startTime":"0","endTime":"0","summary":"Nov 17 (Reuters) - Cosmos Health Q3 revenue USD 17.1 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 17-NOV-202514:11:53.25 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD4NbWHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2584062154","title":"Cosmos Health Q3 Revenue Rises 38% to $17.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584062154","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584062154?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:16","pubTimestamp":1763388988,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. reported record financial results for the third quarter of 2025, with revenue reaching $17.1 million, a 38% increase from $12.4 million in the same period of 2024. Gross profit rose 116% to $2.6 million. Adjusted EBITDA increased by 74%. Net income  per share improved to $ from $ in Q3 2024, and adjusted EPS improved to $ from $. For the nine months ended September 30, 2025, revenue was $45.6 million, up 13% from $40.2 million in the prior-year period, with adjusted EPS turning positive to $0.02 from $ last year. The company ended the quarter with a cash position of $4.6 million, up from $0.7 million. Business developments included record performance across all core segments, continued growth in contract manufacturing at Cana Laboratories, strong sales through Decahedron in the UK, increased volumes in the CosmoFarm distribution business, and international expansion of proprietary brands such as Sky Premium Life. Cosmos Health also secured a $300 million financing fa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL77V60m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2584462150","title":"CORRECTED-BRIEF-Cosmos Health Q3 Adjusted EBITDA USD 185 thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2584462150","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584462150?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:15","pubTimestamp":1763388946,"startTime":"0","endTime":"0","summary":"CORRECTED-BRIEF-Cosmos Health Q3 Adjusted EBITDA USD 185 thousand\n\n\nNov 17 (Reuters) - Cosmos Health Q3 revenue USD 17.1 million.\n\nQ3 gross profit USD 2.6 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nPLX87C561:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2584862139","title":"Cosmos Health Q3 Revenue USD 17.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584862139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584862139?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:15","pubTimestamp":1763388901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nPLX87C561:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COSM","BK4175"],"gpt_icon":0},{"id":"2584624680","title":"Corrected-Cosmos Health Q3 Adjusted Ebitda USD 185 Thousand (Corrects Amount)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584624680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584624680?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:15","pubTimestamp":1763388901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nPLX87C561:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COSM","BK4175"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cosmoshealthinc.com","stockEarnings":[{"period":"1week","weight":0.0678},{"period":"1month","weight":0.222},{"period":"3month","weight":-0.4861},{"period":"6month","weight":0.1509},{"period":"1year","weight":-0.1358},{"period":"ytd","weight":0.1042}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.045257},{"month":2,"riseRate":0.571429,"avgChangeRate":0.008447},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.093142},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.1123},{"month":5,"riseRate":0.875,"avgChangeRate":0.099296},{"month":6,"riseRate":0.375,"avgChangeRate":-0.037913},{"month":7,"riseRate":0.5,"avgChangeRate":0.078733},{"month":8,"riseRate":0.5,"avgChangeRate":0.019433},{"month":9,"riseRate":0.5,"avgChangeRate":-0.025566},{"month":10,"riseRate":0.125,"avgChangeRate":-0.192817},{"month":11,"riseRate":0.625,"avgChangeRate":0.848544},{"month":12,"riseRate":0.125,"avgChangeRate":-0.179034}],"exchange":"NASDAQ","name":"COSMOS HEALTH INC","nameEN":"COSMOS HEALTH INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COSMOS HEALTH INC(COSM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest COSMOS HEALTH INC(COSM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"COSMOS HEALTH INC,COSM,COSMOS HEALTH INC股票,COSMOS HEALTH INC股票老虎,COSMOS HEALTH INC股票老虎国际,COSMOS HEALTH INC行情,COSMOS HEALTH INC股票行情,COSMOS HEALTH INC股价,COSMOS HEALTH INC股市,COSMOS HEALTH INC股票价格,COSMOS HEALTH INC股票交易,COSMOS HEALTH INC股票购买,COSMOS HEALTH INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COSMOS HEALTH INC(COSM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest COSMOS HEALTH INC(COSM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction